 |
The Pharmacy Immunization Compliance Policy and Procedure Program
- An outline/plan to implement a 10 - 15 minute vaccination process
- A Bloodborne Pathogen Plan that specifically addresses applicable OSHA Rules and Regulations
- Training videos
Click here. |
 |
Drugs and Treatment
Boehringer Broadens Afatinib Studies
InPharm (01/27/12) Hill, Adam
Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. The new Phase III head and neck trial will be split into two studies read more...
Return to Headlines
FDA Turns Down Expanded Use of Merck’s Vytorin and Zetia
Bloomberg Business Week (01/26/12) Edney, Anna
The FDA did not grant approval for Merck to expand the use of cholesterol drugs Vytorin and Zetia to include prevention of heart attacks and strokes in those with chronic kidney disease. Merck, however, did receive read more...
Return to Headlines
Medication Helps Some With Mild Depression
Reuters (01/26/12) Pittman, Genevra
A new analysis of previous studies on antidepressants published in the Journal of Clinical Psychiatry indicates that those suffering from mild depression may receive some benefit from taking read more...
Return to Headlines
New Mobile App Allows Consumers to Compare Drug Prices at Pharmacies
eWeek (01/26/12) Horowitz, Brian T.
A new mobile app was recently launched by LowestMed which would allow consumers to compare drug prices at pharmacy chains in a 10 mile radius, based on the GPS location of the phone, or within read more...
Return to Headlines
Studies Suggest Avastin May Fight Early Breast Cancer; Drug Lost OK in US for Advanced Cases
Associated Press (01/25/12)
Results from two new studies may reopen debate about the value of Avastin, a breast cancer drug that helped make tumors disappear in certain women with early-stage disease. Avastin recently lost approval for read more...
Return to Headlines
'Magic Mushroom' Trips Point to New Depression Drugs
Reuters (UK) (01/23/12) Kelland, Kate
Two recent small scale British studies have found that psilocybin, the active component in magic mushrooms, affects the brain in ways that could lead to a better understanding of the way read more...
Return to Headlines
|
|
|
Industry News
Amgen to Acquire Micromet
Amgen Press Release (01/26/12)
Amgen and Micromet have announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its read more...
Return to Headlines
Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen
Eli Lilly and Company Press Release (01/24/12)
Elanco, the animal health division of Eli Lilly, has announced that Lilly has signed an agreement to acquire ChemGen, a privately held bioscience company specializing in the development and commercialization of read more...
Return to Headlines
Germany’s Tough Reimbursement Rules Cause Drug Companies to Consider Alternative Drug Trial Solutions
Financial Times (01/24/12) Smith-Parker, Jennifer
Pharmaceutical companies that hope to gain higher reimbursement in Germany must show that a new drug is not only effective, but an improvement on standard care. On Jan. 1, 2011, a law known as read more...
Return to Headlines
Paul Fonteyne Named President and CEO of Boehringer Ingelheim USA Corporation
Boehringer Ingelheim Pharmaceuticals Press Release (01/23/12)
Paul R. Fonteyne has been named U.S. Country Managing Director and President and CEO of Boehringer Ingelheim USA effective January 1, 2012. Fonteyne assumes this role from J. Martin Carroll who remains with read more...
Return to Headlines
UK's NICE Turns Down Cancer Drugs From Merck, Roche, Amgen
Fox Business (01/24/12)
The U.K.'s National Institute for Health and Clinical Excellence recently rejected three drugs from Merck, Roche, and Amgen. The drugs, Erbitux, Astavin, and Vecitibix, respectively, are designed to read more...
Return to Headlines
|
|
|
Healthcare Legislation & Regulation and Medicaid/Medicare
Innovative Drug Approvals Up Sharply in 2011, Gov’t Increasingly Funds Infectious Disease R&D
Associated Press (01/25/12)
Scientific innovation and business opportunity have spurred new treatments for diseases long-ignored by drug companies, winning the pharmaceutical industry the right to market a record number of read more...
Return to Headlines
Rx for Danger: CVS' 'Blacklist' of Some Doctors Sparks Outcry, Legal Action
Orlando Sentinel (FL) (01/21/12) Pavuk, Amy
CVS/pharmacy sent letters to some Florida doctors stating that prescriptions for painkillers and addictive drugs originating from their offices would no longer be filled at CVS locations read more...
Return to Headlines
Senate Watchdog Targets High-Prescribing Medicaid Docs
ProPublica (01/24/2012) Ornstein, Charles; Weber, Tracy
Senator Charles Grassley (R-Iowa) recently sent letters to 34 states in a followup to the letter he sent to all the states in 2010. The initial letter requested information on the top read more...
Return to Headlines
|
Abstract News © Copyright 2012 INFORMATION, INC.
 |
|
|
FEATURED SPONSOR:
|
|
